Sixteen months after partnering with Tubulis, Gilead has decided to acquire the biotech and its portfolio of ADCs.

Digital predictive modeling is being used to simulate extreme distribution conditions and prioritize mitigation, but hybrid ...

Susan Schniepp, Regulatory Compliance Associates Inc., discusses digital twins and AI in pharma, focusing on data integrity, human-in-the-loop roles, and evolving machine learning risks. In part 1 of ...

The acquisition allows Neurocrine to offer three therapies: Ingrezza, Crenessity, and Vykat XR.

TCW funds, an investment management company, released its “TCW Relative Value Mid Cap Fund” fourth-quarter 2025 investor letter. A copy of the letter can be downloaded here. Equities finished the year ...

India’s healthcare and pharmaceutical sector is expected to create over 2 – 2.5 million new jobs by 2030, with nearly 30–35% ...

Intensifying pipeline competition and shorter differentiation windows demand faster, higher-precision launch decisions as most products fail to reach “international excellence” and many generate ...

Halozyme Therapeutics, Inc. (Nasdaq: HALO) ("Halozyme" or the "Company") today announced its wholly-owned subsidiary, Halozyme ...

GE HealthCare is set to release its first-quarter results later this month, with analysts forecasting a single-digit rise in ...

Raman spectroscopy enables detailed comparison of coating composition and uniformity between RLD and generic pellets.

Eli Lilly (LLY) stock drops after FDA approves Foundayo oral GLP-1 drug for obesity, intensifying competition and highlighting side effect concerns.

SHELTON, CT / ACCESS Newswire / April 7, 2026 / NanoViricides, Inc., a publicly traded company (NYSE American:NNVC) ...